No description available.

Hyaloperonospora arabidopsidis (Hpa) is a naturally occurring oomycete pathogen on Arabidopsis thaliana. It is related to downy mildews of economically important crops such as cabbage, kale and broccoli, belonging to the Brassicaceae family. Downy mildew pathogens are obligate biotrophs that extract nutrients exclusively from living plant cells. As a part of its obligate biotrophy lifestyle, Hpa has lost the ability to assimilate inorganic nitrogen and sulfur. It thus has to acquire these nutrients from the host in an organic form; possibly amino acids. Using a reverse genetic approach, I was able to identify two host amino acid transporters that are up-regulated during Hpa infection: AAP3 and AAP6. Both of these transporters are localized in the vasculature of the plant, AAP3 mostly in the root, and AAP6 in the roots and shoots. Using transgenic lines of Arabidopsis containing transcriptional and translational reporter fusion constructs for these genes, I found that AAP3 displays increased mRNA accumulation which is attributable to an increased promoter activity in regions of shoot tissue colonized by Hpa. On the other hand, AAP6 displays a mild increase in mRNA accumulation under Hpa infection, but the induction becomes more prominent at the protein level as seen by fluorescence from GFP fused to AAP6. Surprisingly, null mutants of AAP3 did not impact Hpa growth whereas null mutants of AAP6 made the plant more susceptible to Hpa. Furthermore, aap6 mutants accumulate fewer free amino acids in the phloem compared to wild-type plants when infected with Hpa. Together, these results suggest that AAP6 acts a nutritional starvation gene for the pathogen and hence aids the plant during infection. While we now know more about AAP3's regulation during infection, its function remains to be elucidated. To successfully colonize a plant, a pathogen must be able to achieve both suppression of plant immunity and acquisition of nutrients from the plant host. While the former has been well studied, research on the latter is sparse. This work was a step in the direction to increase our understanding of potential players in nutrient acquisition by pathogens. / Doctor of Philosophy / A key aspect of achieving and maintaining food security is sustainable agricultural production. This is endangered by plant diseases that lead to large losses in crop production. All plant pathogens have to acquire food and nutrients from the plants they infect. Understanding how they acquire nutrients from the plant at a molecular level can give us insight into potential methods to prevent this and hence reduce the impact of plant diseases. One such nutrient is nitrogen. Nitrogen is essential to all of an organism’s cellular and metabolic processes. Organisms utilize nitrogen by converting it from inorganic forms such as nitrates to organic forms such as amino acids. Some plant pathogens, such as Hyaloperonospora arabidopsidis (Hpa), which causes downy mildew disease on the model plant Arabidopsis, complete their entire life cycle on a living plant. They are also unable to convert the inorganic nitrogen to organic forms and hence depend on acquiring organic forms of nitrogen from the plant. Thus, it is important to understand how they acquire amino acids from the plant. Plants use amino acid transporters that serve as a siphon or a pump in moving amino acids from one region of the plant to another. It is possible that pathogens manipulate plant’s amino acid transporters to move amino acids towards the infection site while, at the same time, plants might use another set of transporters to move amino acids away from the pathogen. This work was an attempt at understanding this potential role of plant amino acid transporters in plant-pathogen interactions using the model system of Hpa and Arabidopsis.

Charles University Faculty of Pharmacy in Hradec Králové Department of Pharmacology & Toxicology Student: Veronika Křečková Supervisor: PharmDr. Lukáš Červený, Ph.D. Title of diploma thesis: Role of drug transporters in placental transfer of entecavir Entecavir (ETV), an analogue of guanosine, is a highly efficient anti-hepatitis B antiviral drug. It is the first-line therapy for both adults and children. Its use in pregnancy is limited due to a number of factors, including lack of data on placental pharmacokinetics. The placental transition of drugs is frequently controlled by drug transporters. ATP-binding (ABC) transporters, P-glycoprotein (P-gp), breast cancer resistance protein (BCRP) or multidrug resistance-associated protein 2 (MRP2) localized in the apical membrane of syncytiotrophoblast and pumping their substrates in the feto-maternal direction belong to most significant determinants of placental pharmacokinetics. Moreover placental transport of nucleoside-derived drugs can be affected by the activity of nucleoside transporters (NTs); equilibrative nucleoside transporters (ENTs) mediate facilitated diffussion, while the concentrative nucleoside transporters (CNTs) control active influx of their substrates. The aim of the diploma thesis was to describe the role of P-gp, BCRP, MRP2 and NTs (ENTs and...

No description available.

Cancer continues to be a leading cause death in the United States despite improved treatments. Cancerous lesions form after acquiring oncogenic driver mutations or losing tumor suppressor function in normal cells. Traditional therapies have included use of genotoxic substances that take advantage of the increased growth rate and loss of tumor suppressor function to cause cell death. One such drug is the anthracycline antibiotic doxorubicin (DOX). DOX interchelates into DNA and disrupts transcriptional machinery while also poisoning topoisomerase II. This results in single and double stranded DNA breaks, which if severe enough leads to either necrotic or apoptotic cell death. DOX has been very effective at treating several different cancers and is still widely used today however its clinical use is limited due to cumulative dose dependent cardiotoxicity. Therefore, combination therapy targeting survival pathways is utilized to minimize the cumulative dose of DOX without ameliorating its anti-tumor effects. We investigated the potential anti-cancer effects of combining the dual PI3K/mTOR inhibitor, BEZ235 (BEZ), with DOX in pancreatic, breast and other cancer cells lines as well as its associated effects on the heart. Our results showed that co-treatment of BEZ with DOX increased apoptosis in a manner that was dependent on inhibition of the AKT survival pathway. Moreover, BEZ co-treatment with DOX had additive effects towards cell viability while it significantly enhanced necrotic cell death compared to either drug alone. Furthermore, we observed that physiological concentrations of BEZ inhibited ABCB1 efflux resulting in increased intracellular accumulation of DOX, which led to increased DNA damage. In addition, BEZ in combination with gemcitabine (Gem) reduced cell proliferation but did not enhance necrosis or apoptosis. Treatment with BEZ and DOX in mice bearing tumor xenographs reduced tumor growth as compared to BEZ, DOX or Gem. Moreover, BEZ reduced DOX toxicity in rat myoblast cells and did not potentiate the effects of DOX in tumor-bearing mice. We propose that combining BEZ with DOX could be a novel therapeutic approach for the treatment of patients with cancer in the hope of improving the prognosis of this deadly disease.

Notre étude est consacrée à la caractérisation des mécanismes d'adaptation métabolique des neutrophiles au cours de l'inflammation et plus particulièrement au cours de leur recrutement dans les voies aériennes des patients atteints de mucoviscidose (cystic fibrosis ou CF en anglais). Dans la mucoviscidose, nous avons précédemment décrit que les neutrophiles présents dans la lumière du poumon sont viables et soumis à une reprogrammation, notamment via l'activation de la voie anabolique mTOR. Ce travail est fondé sur les propriétés spécifiques de ligands solubles dérivés des domaines liant le récepteur (RBD, pour Receptor-Binding Domain) des glycoprotéines d'enveloppes rétrovirales permettant leur utilisation pour la détection de transporteurs métaboliques à la surface des cellules. Dans un premier temps, nous avons validé l'utilisation de ce nouveau groupe de marqueurs pour identifier et caractériser le phénotype métabolique des leucocytes CF obtenus à partir d'échantillons de différents compartiments (sang et expectorât pulmonaire). Dans un deuxième temps, l'étude de l'expression de ces transporteurs métaboliques sur les neutrophiles sanguins de patients atteints de CF ou de polyarthrite rhumatoïde et de sujets contrôles, a permis la distinction de phénotypes métaboliques au niveau systémique selon différents états inflammatoires. Ensuite, nous avons comparé l'expression des transporteurs métaboliques entre les neutrophiles sanguins et pulmonaires de patients CF et révélé une adaptation métabolique de ces cellules lors de leur recrutement vers les poumons. Enfin, les neutrophiles présents dans les voies aériennes des patients CF présentent une modulation de leur activité transcriptionnelle. De façon surprenante, nos travaux démontrent que malgré leur reprogrammation, les neutrophiles recrutés vers les poumons CF sont fonctionnellement compétents, ajoutant ainsi un nouvel angle d'approche dans l'étude des neutrophiles au cours de l'inflammation, notamment dans le cas de la pathologie pulmonaire liée à la mucoviscidose. / The present study focuses on adaptive metabolic steps adopted by neutrophils during inflammation, particularly during their recruitment into the cystic fibrosis (CF) airways. In CF, we previously described that airway neutrophils are alive and undergo reprogramming, featuring notably the activation of the anabolic mTOR pathway. The present work is based on specific properties of soluble ligands derived from the receptor-binding domains (RBD) of retroviral glycoprotein envelopes, which can be used for the detection of metabolite transporters at the cell surface. First, we validated the use of this new set of markers for the identification and characterization of the metabolic phenotype of CF leukocytes obtained from distinct compartments (blood and sputum). Second, by studying the metabolite transporter expression on blood neutrophils from CF or rheumatoid arthritis patients and control subjects, we distinguished metabolic phenotypes characteristic of specific inflammatory states. Then, we compared metabolite transporter expression between CF blood and airway neutrophils and showed that neutrophils undergo significant metabolic adaptation upon recruitment into the lungs. Finally, we demonstrated that CF airway neutrophils display significant transcriptional modulation and that despite their metabolic reprogramming, they remain functionally competent, thus adding an additional angle of approach to neutrophil studies with regard to inflammation, notably during CF airway disease.

Au Mexique l’état de Tamaulipas est susceptible de devenir l'un des plus grands producteurs de mezcal. Contrairement à d’autres boissons alcoolisées, la mycoflore responsable de la fermentation alcoolique du mezcal n'a pas été pleinement identifiée ou caractérisée métaboliquement. Il est d'un grand intérêt industriel de savoir si les levures indigènes impliquées dans la fermentation de moûts d’agave ont une forte nature fructophilique qui serait induite par la composition naturelle riche en fructose du moût. De plus, la caractérisation cinétique des levures et au niveau moléculaire des transporteurs impliqués dans la consommation de fructose par cette flore est pertinente étant donné que des études sur l'utilisation des hexoses par Saccharomyces cerevisiae n’ont pas montré que les transporteurs de glucose et de fructose étaient différents. Dans ce travail, la population levurienne étudiée était de 17 isolats, à partir de 103 initialement isolés de la mezcaleria "El Palmar" Emilio Lozoya, situé à San Carlos (Tamaulipas, Mexique) au niveau de différentes étapes. Seules les levures de l’espèce Saccharomyces cerevisiae ont été retenues et étudiées. En particulier de polymorphismes des 2 gènes des transporteurs principaux de sucres associes au fructose consume HXT1 et HXT3, a été évalué en comparaison à une souche de référence. Les résultats obtenus dans cette étude suggèrent la nécessité d'une analyse approfondie afin de préciser les liens entre la fructophilie et l'expression et / ou la structure des gènes des transporteurs de sucres lors de la fermentation alcoolique. / The Mexican state of Tamaulipas has the potential to become one of the main producers of mezcal. But contrary to what is known about other alcoholic beverages, the mycoflora involved in this alcoholic fermentation has not been completely identified nor characterised from the metabolic point of view. There is an increasing industrial interest on knowing if the native yeasts associated to agave must fermentations possess a fructophilic behaviour, favoured by the natural high fructose composition of the agave musts. Moreover, the kinetic characterisation of these yeasts and the molecular analysis carried out on the hexose transporters genes reported to be involved in the glucose and fructose consumption is pertinent, and several studies on Saccharomyces cerevisiae have demonstrated a differential preference for each hexose. In this study, a set of 17 yeast isolates were chosen from an original collection of 103 yeast isolated at the mezcalería El Palmar Emilio Lozoya, which is located at San Carlos (Tamaulipas, Mexico) from different stages of the fermentation. Only those belonging to S. cerevisiae specie were studied, mainly concerning the polymorphisms found on their two main hexose transporter genes associated to a preferential consumption of fructose, HXT1 and HXT3, and results compared to a control strain. The results obtained showed that there is no a direct link between the fructophilic phenotype and/or the structure of these genes and that more studies are needed to establish such relationships

ARE subfamily proteins belonging to ABC transporters confers a different degree of resistance to macrolides, linkosamides and streptogramins antibiotics. Among the most clinically ARE subfamily proteins in staphylococci is Vga(A) protein lead to the award resistance to streptogtramins A. In 2006, discovered the new variant called the Vga(A)LC, which in addition to streptogramins A resistance also confers linkosamides. Vga(A) and Vga(A)LC differ in only 7 amino acids, yet confer different resistance phenotypes. In previous experiments it was found that the central role in determining substrate specificity play a 4 amino acid differences that accumulate in the section of 15 amino acids within the linker connecting the two ABC domains (positions 212, 219, 220 and 226). The combination of amino acids LGAG Vga(A) increases resistance to streptogramins A while present in combination SVTS Vga(A)LC increased resistance to linkosamides. Although in this subfamily includes a large number of resistance proteins, the mechanism of resistance has not yet been established with certainty. The aim was to create a new Vga(A) variants that contain specific combinations of amino acids for Vga(A) and Vga(A)LC protein at positions 212, 219, 220 and 226 and compared their ability to grant resistance to linkosamides. We also...

L’efficacité des chimiothérapies est limitée par la surexpression de pompes d’efflux adressées à la membrane plasmique des cellules cibles. En effet, celles-ci réduisent le taux intracellulaire des médicaments anticancéreux, antiviraux, antifongiques et antibactériens. La P-gp/ABCB1 est la plus impliquée dans ce phénomène, suivie de MRP1/ABCC1 et de BCRP/ABCG2. Une approche pour surmonter ce phénomène est de développer des médicaments qui ne soient pas expulsés par ces pompes. Dans ce contexte, nous avons développé une nouvelle classe d’inhibiteurs de la protéase du VIH-1 qui ne sont ni transportés par P-gp ni par BCRP. Ils sont ainsi des candidats intéressants aux trithérapies contre le SIDA. Un point clé pour comprendre comment ces transporteurs font traverser les médicaments à travers la membrane est d’identifier des nouvelles structures. Ainsi, nous avons résolu trois structures de P-gp de souris. Une d’entre-elles est complexée à un nano-anticorps lié au premier NBD («nucleotide-binding domain»), qui fige la P-gp dans une nouvelle conformation ouverte vers l'intérieur. Pour finir, nous avons localisé deux sites de liaison de P-gp en caractérisant les modes d'inhibition de deux inhibiteurs précédemment cocristallises avec la pompe. Ceci permet de mieux comprendre le mécanisme de translocation et offre la possibilité de cibler plus précisément ces sites pour développer des modulateurs de cette pompe / Resistance to chemotherapy is partly due to efflux pumps expressed in the plasma membrane which prevents the accumulation of anticancer, antiviral, antifungal and antibacterial drugs in target cells. Three human ABC transporters are particularly involved in MDR phenotype: P-gp/ABCB1, MRP1/ABCC1 and BCRP/ABCG2. Among the different approaches used to overcome the resistance linked to these transporters, the development of non-substrate drugs MDR-ABC transporters has been described. Here, new class of HIV-1 protease inhibitors not recognized by P-gp/BCRP were identified, promising to be attractive candidates to HAART therapy. Since the determination of the X-ray structures in different conformations is a key point to understand how MDR-ABC transporters translocate drugs across the plasma membrane, the crystal structures of three inward-facing conformations of mouse P-gp were resolved. One structure has a camel nanobody bound to the C-terminal side of the first nucleotide-binding domain, revealing a unique epitope on P-gp and freezing a new open-inward conformation. Finally, the enzymatic characterization of two inhibitors co-crystallized with the mouse P-gp has allowed to localize two main binding sites by which drugs efflux occurs. These results bring new findings of the drug-efflux mechanism and offer the possibility to target more precisely those sites to develop modulators of this pump

Les travaux présentés ici portent sur les P1B-ATPases HMA2, HMA3 et HMA4 d'Arabidopsis thaliana, transporteurs de cations présents sur différentes membranes chez les plantes. L'étude du contenu cationique de plantes mutantes hma2 et hma4 a précisé le rôle important de HMA4 dans la translocation du Zn et du Cd vers les parties aériennes et sa forte affinité pour le Cd. La mesure du contenu cationique de graines de différents génotypes a montré un effet complexe des modulations de l'expression des gènes correspondants, la surexpression du gène HMA4 conduisant à une teneur en Zn de la graine similaire à celle du mutant perte de fonction. Ces résultats confirment l'importance de HMA4, et montrent la nécessité d'adapter la construction aux objectifs biotechnologiques visés. Afin de préciser le rôle de résidus conservés au sein de la famille des P1B-ATPases, j'ai étudié l'effet de l'expression d'un variant de HMA4 pour le domaine fortement conservé CPC. Les résultats obtenus in planta suggèrent une interaction avec la version native du transporteur entraînant une perte de l'activité de HMA4. Pour mener une approche structure/fonction sur ces transporteurs, L. lactis a été défini comme le meilleur candidat pour produire HMA3. Suite à l'expression de HMA3, un gain de tolérance au Cd a été observé et a permis de valider 3 variants de HMA3, mutés au niveau du pore ou du site d'hydrolyse de l'ATP, comme affectés dans l'activité de la protéine. Les membranes de L. lactis enrichies en transporteur HMA3 ou de ses variants ont permis une reconstitution in vitro en protéoliposomes permettant de mesurer une activité de transport du Cd compétitive avec le Zn et inhibée par le vanadate. / Work presented here is about Arabidopsis thaliana P1B-ATPases HMA2, HMA3 et HMA4, cation transporters found in different plant membranes. Cation content study of mutant plants hma2 and hma4 precised important role of HMA4 in upward translocation of Zn and Cd, and its high affinity for Cd. Cation content measure of seeds from different genotypes showed a complex effect of modulations of related genes expression levels, HMA4 overexpression leading to a seed Zn content similar the loss-of-function mutant one. These results confirm the importance of HMA4 and show the needs to adapt construction to biotechnological aims. To precise the role of residus conserved among the P1B-ATPases family, I studied the effect of the expression of a HMA4 variant for the highly conserved domain CPC. Obtained in planta results suggest an interaction with the native transporter leading to a loss of HMA4 activité. To perform a structure/function study on these transporters, L.lactis has been shown as the best candidate to produce HMA3. Due to HMA3 expression, a gain of Cd tolerance has been observed and allowed to validate three HMA3 variants, mutated in the pore or the ATP hydrolysis site, as affected in the protein activity. L.lactis membranes enriched with HMA3 or variants allowed an in vitro reconstitution in proteoliposomes and the measurement of a Cd transport activity competing with Zn and inhibited by vanadate.